Your browser doesn't support javascript.
loading
Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort.
Cressatti, Marisa; Pinilla-Monsalve, Gabriel D; Blais, Mathieu; Normandeau, Catherine P; Degroot, Clotilde; Kathol, Iris; Bogard, Sarah; Bendas, Anna; Camicioli, Richard; Dupré, Nicolas; Gan-Or, Ziv; Grimes, David A; Kalia, Lorraine V; MacDonald, Penny A; McKeown, Martin J; Martino, Davide; Miyasaki, Janis M; Schlossmacher, Michael G; Stoessl, A Jon; Strafella, Antonio P; Fon, Edward A; Monchi, Oury.
Afiliação
  • Cressatti M; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
  • Pinilla-Monsalve GD; Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, AB, Canada.
  • Blais M; Department of Medicine, School of Medicine, Queen's University, Kingston, ON, Canada.
  • Normandeau CP; Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada.
  • Degroot C; Axe Neurosciences du Centre de Recherche du CHU de Québec - Université Laval, Québec, QC, Canada.
  • Kathol I; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
  • Bogard S; Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, AB, Canada.
  • Bendas A; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
  • Camicioli R; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
  • Dupré N; Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, AB, Canada.
  • Gan-Or Z; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
  • Grimes DA; Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada.
  • Kalia LV; Department of Medicine, Division of Neurology, University of Alberta, Edmonton, AB, Canada.
  • MacDonald PA; Parkinson and Movement Disorders Program and the Complex Neurologic Symptoms Clinic, Kaye Edmonton Clinic, University of Alberta, Edmonton, AB, Canada.
  • McKeown MJ; Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, Canada.
  • Martino D; Axe Neurosciences du Centre de Recherche du CHU de Québec - Université Laval, Québec, QC, Canada.
  • Miyasaki JM; Faculty of Medicine, Department of Medicine, Université Laval, Québec, QC, Canada.
  • Schlossmacher MG; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
  • Stoessl AJ; Division of Neurology and Program in Neuroscience, The Ottawa Hospital, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada.
  • Strafella AP; Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
  • Fon EA; Morton and Gloria Shulman Movement Disorder Unit and the E. J. Safra Parkinson Disease Program, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Monchi O; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
J Parkinsons Dis ; 2024 Sep 19.
Article em En | MEDLINE | ID: mdl-39302382
ABSTRACT

Background:

Enhancing the interactions between study participants, clinicians, and investigators is imperative for advancing Parkinson's disease (PD) research. The Canadian Open Parkinson Network (C-OPN) stands as a nationwide endeavor, connecting the PD community with ten accredited universities and movement disorders research centers spanning, at the time of this analysis, British Columbia, Alberta, Ontario, and Quebec.

Objective:

Our aim is to showcase C-OPN as a paradigm for bolstering national collaboration to accelerate PD research and to provide an initial overview of already collected data sets.

Methods:

The C-OPN database comprises de-identified data concerning demographics, symptoms and signs, treatment approaches, and standardized assessments. Additionally, it collects venous blood-derived biomaterials, such as for analyses of DNA, peripheral blood mononuclear cells (PBMC), and serum. Accessible to researchers, C-OPN resources are available through web-based data management systems for multi-center studies, including REDCap.

Results:

As of November 2023, the C-OPN had enrolled 1,505 PD participants. The male-to-female ratio was 1.771, with 83% (n = 1098) residing in urban areas and 82% (n = 1084) having pursued post-secondary education. The average age at diagnosis was 60.2±10.3 years. Herein, our analysis of the C-OPN PD cohort encompasses environmental factors, motor and non-motor symptoms, disease management, and regional differences among provinces. As of April 2024, 32 research projects have utilized C-OPN resources.

Conclusions:

C-OPN represents a national platform promoting multidisciplinary and multisite research that focuses on PD to promote innovation, exploration of care models, and collaboration among Canadian scientists.
Teamwork and communication between people living with Parkinson's disease (PD), physicians, health professionals, and research scientists is important for improving the lives of those living with this condition. The Canadian Open Parkinson Network (C-OPN) is a Canada-wide initiative, connecting the PD community with ten accredited universities and movement disorders research centers located in ­ at the time of this analysis­British Columbia, Alberta, Ontario, and Quebec. The aim of this paper is to showcase C-OPN as a useful resource for physician and research scientists studying PD in Canada and around the world, and to provide snapshot of already collected data. The C-OPN database comprises de-identified (meaning removal of any identifying information, such as name or date of birth) data concerning lifestyle, disease symptoms, treatments, and results from standardized tests. It also collects blood samples for further analysis. As of November 2023, C-OPN had enrolled 1,505 PD participants across Canada. Most of the participants were male (64%), living in urban areas (83%), and completed post-secondary education (82%). The average age at diagnosis was 60.2±10.3 years. In this paper, we look at environmental factors, motor and non-motor symptoms, different disease management strategies, and regional differences between provinces. In conclusion, C-OPN represents a national platform that encourages multidisciplinary and multisite research focusing on PD to promote innovation and collaboration among Canadian scientists.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Parkinsons Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Parkinsons Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá